https://www.selleckchem.com/pr....oducts/4-phenylbutyr
CGM is an evidence-based intervention to improve glycemic control in persons with T1D and T2D using insulin. Use of CGM in persons with T2D not using insulin is not well studied. Existing clinical evidence for the use of CGM in persons with T2D is reviewed with a focus on persons with T2D not using insulin. Additional perspective and consideration are provided on the role and rationale for using CGM in persons with T2D not using insulin. On the basis of available evidence, persons with T2D not using insulin benefit c
Curtir
Comentario
Compartilhar
